Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

July 22, 2016 - 7:19 a.m.
European CHMP Adopts Positive Opinion on Gilead’s Type II Variation Application for Truvada® for Reducing the Risk of Sexually Acquired HIVPrinter Friendly Version 
July 21, 2016 - 4:32 p.m.
Gilead’s Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) Meets Primary 48-Week Objective in Two Phase 3b StudiesPrinter Friendly Version 

Upcoming Events

Monday, July 18, 2016 through Friday, July 22, 2016
21st International AIDS Conference
LocationDurban, South Africa
Monday, July 25, 2016 4:30 p.m. ET
Second Quarter 2016 Gilead Sciences Earnings Conference Call

Most Viewed Links

Updated 07/12/16
1.SEC Filings
3.Annual Reports
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 07/04/16 - 07/11/16

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.